@article{69d08ecbef0342e5a4670730fa240a52,
title = "Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study",
author = "Rickels, {Michael R.} and Ruedy, {Katrina J.} and Foster, {Nicole C.} and Pich{\'e}, {Claude A.} and Helene Dulude and Sherr, {Jennifer L.} and Tamborlane, {William V.} and Bethin, {Kathleen E.} and DiMeglio, {Linda A.} and Wadwa, {R. Paul} and Ahmann, {Andrew J.} and Haller, {Michael J.} and Nathan, {Brandon M.} and Marcovina, {Santica M.} and Emmanouil Rampakakis and Linyan Meng and Beck, {Roy W.}",
note = "Funding Information: This work was funded by a grant from the Leona M. and Harry B. Helmsley Charitable Trust; by the National Center for Research Resourcesand theNationalCenter forAdvancing Translational Sciences, National Institutes of Health, throughgrantsUL1TR000003 (University of Pennsylvania), UL1TR000064 (University of Florida), and UL1TR001108 (Indiana University); and by Locemia Solutions ULC. Studies at the Barbara Davis Center for Childhood Diabetes were performed in their infusion center and not the hospital Clinical Translational Research Center. Locemia Solutions provided the intranasal glucagon product.",
year = "2016",
month = oct,
day = "1",
doi = "10.2337/dci16-0025",
language = "English (US)",
volume = "39",
pages = "e193--e194",
journal = "Diabetes care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "10",
}